Universal Biosensors, Inc.

Mr Andrew Denver BSc. (Hons), M.B.A., F.A.I.C.D.
Chairman

Andrew has extensive expertise that is relevant to the Company, including in assisting the commercialization of several technology companies. Andrew has a wide ranging knowledge of the life sciences industry of which our Company is a part, risk assessment, financial reporting experience and general management, which are important in the success of our business. Andrew has served as a director of the Company since December 2002 and as Chairman since September 2005. Andrew has been a member of the Remuneration and Nomination Committee since January 2008 and was a member of the Audit & Compliance Committee from 2006 to January 2008 and from January 2010 to July 2010. Andrew has served as a director of Universal Biosensors Pty Ltd since December 31, 2002. Between 2002 and 2005, Andrew was President of Pall Asia, a subsidiary of Pall Corporation after the acquisition by Pall Corporation of US Filter's Filtration and Separations business, where he was also President. Pall Corporation is a technology based filtration, separation and purification multinational company. Andrew is a director and founder of PFM Cornerstone Ltd and The Principals Funds Management Pty Ltd, companies which help Australian technology businesses, which are predominately in the life sciences industry, commercialize their technologies. Andrew is a non-executive director of SpeeDx Pty Ltd and Cochlear Ltd, all of which are life sciences companies, and until September 2010 and October 2008, was also a non-executive director of CathRx Ltd and Anzon Australia Ltd, respectively. Andrew graduated from the University of Manchester with a Bachelor of Science Degree (Honors) in Chemistry and achieved a distinction in his M.B.A. at the Harvard Business School and is a Fellow of the Australian Institute of Company Directors.

back to top

Mr Paul Wright M.A., F.A.I.C.D.
Chief Executive Officer

Paul was appointed as Chief Executive Officer and a director of the Company on February 24, 2011with an effective date of March 1, 2011. Paul has experience as Chief Executive Officer with two global technology companies and extensive experience in international management consulting and commercial development with a focus on manufacturing industries. Between 2008 and 2011, Paul has acted as a company director for two Australian private companies (Metallic Waste Solutions Pty Ltd and Comcater Pty Ltd). During 2006 and 2007, Paul was Chief Executive Officer of Vision BioSystems, a major subsidiary of Vision Systems Limited, which develops, manufactures and markets diagnostic instruments and consumables worldwide. Following the acquisition of Vision Systems Limited by Danaher Corporation in 2006, Paul worked for Danaher Corporation to assist with the integration of Vision Systems into the new parent until 2007. From 1999 to 2006, Paul was Chief Executive Officer of Invetech, a leading international product development consultancy. Prior to this, Paul gained extensive experience in international strategy consulting and commercial development, with a focus on manufacturing industries including roles at TNT Logistics and Bain & Company. Paul holds a Masters degree in Aeronautical Engineering from the University of Cambridge, a Diploma in Production Methods & Management from the University of Cambridge and has studied Corporate Finance at the London Business School. Paul is a Fellow of the Australian Institute of Company Directors.

back to top

Dr Colin Adam B.E. (Met.), Ph.D.
Non-Executive Director

Colin has extensive knowledge which is relevant to our Company of the life sciences industry and biomedical and general scientific research and development generally. Colin also has extensive project management experience in commercialization of technologies, such as ours, with global potential. Colin has been a non-executive director since December 2006 and a director of Universal Biosensors Pty Ltd between July 2002 and December 2006. Colin has been a member of the Audit & Compliance Committee since July 2010 and between 2006 and November 2010 was a member of the Remuneration and Nomination Committee. In 2000, Colin was the Acting Chief Executive of the Commonwealth Scientific and Industrial Research Organization (¡§CSIRO¡¨), the peak Australian Government body with a mission for technological development and industrial research and development, which includes significant research and development in the life sciences industry of which we are a part. Between 1996 to 1999, Colin was Deputy Chief Executive directly responsible for all the CSIRO's commercial activity, including the start-up of several spin-off companies from the organizations extensive research portfolio. Prior to working with the CSIRO, Colin's career has included executive positions within the US aerospace industry for Pratt & Whitney Aircraft in Florida and Allied Corporation in New Jersey. Colin has served as a member of the Australian Government's Industry Research and Development Board, the Australian Prime Minister's Science Engineering and Innovation Council and the Victorian Premier's Science, Engineering and Technology Taskforce. Colin is a director and founder of PFM Cornerstone Ltd and The Principals Funds Management Pty Ltd, companies which help Australian technology businesses, which are predominately in the life sciences industry, commercialize their technologies. Colin was appointed as a director of CathRx Ltd, a life sciences company, in September 2010. Until January 2010, August 2005 and September 2006, Colin served on the Boards of Ausmelt Limited, Ceramic Fuel Cells Ltd and Tele-IP Ltd, respectively, the latter in the capacity of its non-executive Chairman. Colin has a Bachelor of Metallurgical Engineering Degree and a Ph.D. in Metallurgy from the University of Queensland.

back to top

Mr Denis Hanley A.M., M.B.A., F.C.P.A., F.A.I.C.D.
Non-Executive Director

Denis has been a successful angel investor, assisting the commercialization of several Australian technologies. Denis has extensive knowledge relevant to our Company, including of the life sciences industry of which our Company is a part, risk assessment, financial reporting experience and general management. Denis has served as a non-executive director since September, 2001 and is a member of the Audit & Compliance Committee. Denis is a qualified accountant and company director with more than 35 years experience in the management of technology-based growth businesses, such as our Company. Denis has significant experience in developing and commercializing new technology based Australian corporations to become successful global entities. His experience includes 14 years as chief executive officer of Memtec Limited, growing the start-up company to become an international force in filtration and separations technology, listed on the New York Stock Exchange. Prior to this, Denis spent more than a decade at global medical company Baxter Healthcare, both in the U.S. and also as Australian Managing Director. Denis has served on the Australian Industry Research and Development Board and various technology councils and roundtables. Denis is a director and founder of PFM Cornerstone Ltd, a company which helps Australian technology businesses, which are predominately in the life sciences industry, commercialize their technologies. Denis is currently non-executive Chairman of Pharmaxis Ltd and CathRx Ltd, which are both life sciences companies, and until October 2007 was non-executive director of Lochard Ltd. Denis holds an M.B.A. with High Distinction from Harvard Graduate School of Business, where he was named a Baker Scholar.

back to top

Mr Andrew Jane BSc. (Hons), MSc.
Non-Executive Director

Andrew has extensive experience relevant to our Company, including in biomedical research and development project management, marketing and business development. Andrew's primary expertise is in the commercialization and globalization of technology based products, such as those products being developed by us. Andrew has served as a non-executive director since August 2006 and is Chairman of the Remuneration and Nomination Committee. Andrew was a director of Universal Biosensors Pty Ltd between August 15, 2006 and December 6, 2006. In 2003, Andrew joined CM Capital Investments Pty Ltd, a Brisbane based venture capital investment company, as an Investment Manager and was promoted to Partner in 2006. Prior to this, Andrew worked for Lake Technology, an audio technology company as Director of Business Development and Licensing, where he worked closely with Lake Technology's strategic partner, Dolby Laboratories an audio technology company in San Francisco, and was responsible for a significant number of global licensing deals during his four years there. Prior to Lake Technology, Andrew held R&D management positions of increasing responsibility at AGEN Biomedical and the CSIRO. Andrew is currently a director of a number of life sciences companies including Advent Pharmaceuticals Pty Ltd, Altiris Therapeutics, Inc., Piedmont Pharmaceuticals, Inc., Piedmont Pharmaceuticals Pty Ltd, SpeeDx Pty Ltd and is an observer to the Board of Metastatix, Inc. and Osprey Medical, Inc. Andrew received his Master of Science in Instrumentation from the University of Manchester Institute of Science and Technology and holds a Bachelor of Science (Honors) in Physics from St Andrews University in Scotland.

back to top

Mr Marshall Heinberg B.S. (Hons), J.D. [Appointed on 11 January 2010]
Non-Executive Director

Marshall has extensive experience relevant to our Company including insight into the global capital markets and has worked with several life science and technology companies. Marshall was appointed a non-executive director of the Company in January 2010 and has served as a member of the Remuneration and Nomination Committee since November 2010. Marshall is head of Oppenheimer's Investment Banking Department and a Senior Managing Director of the firm. Marshall began his investment banking career in 1987 as an Associate in the Corporate Finance Division of Oppenheimer & Company, which was acquired by the Canadian Imperial Bank of Commerce (CIBC) in 1997. Marshall held several senior roles at CIBC World Markets including serving as a member of the U.S. Management Committee, the Deals Committee which approved U.S. corporate finance debt capital decisions and the Investment Committee which approved private equity and fund investments. Marshall also served as a member of the Equity Transaction Committee and Financial Advisory Transaction Committee. Over the course of his career, Marshall has held responsibility for various industry sectors including environmental, industrial growth, technology and telecommunications. His transaction experience includes public and private debt and equity financings, as well as numerous exclusive sale and strategic advisory assignments. Marshall was named Head of CIBC's U.S. Investment Banking Department in 2001. Upon the acquisition of CIBC's U.S. wholesale business in 2008, Marshall was named head of Oppenheimer's Investment Banking Department. Marshall is also a non-executive director of Image Entertainment, Inc., a leading independent licensee and distributor of entertainment programming in North America. Marshall has extensive experience working with both leading growth companies as well as financial sponsors. Prior to joining Oppenheimer, Marshall practiced corporate law for approximately four years. Marshall graduated from the University of Pennsylvania, the Wharton School with honors, with a degree in economics. He received his law degree from Fordham Law School.

back to top

Dr Jane Wilson M.B.B.S., M.B.A., F.A.I.C.D.
Non-Executive Director

Jane is a professional company director with extensive experience relevant to our Company in medicine and finance, with a special interest in the commercialization of research in the biotechnology sector. Jane has served as a non-executive director since December 2006. Jane is Chairman of the Audit & Compliance Committee and until January 2008, a member of the Remuneration and Nomination Committee. Jane is the Finance Director of the Winston Churchill Memorial Trust and was the inaugural Chair of Horticulture Australia Ltd from 2000 to 2004. She is involved in a number of charitable and cultural organizations and has also served on the Queensland Government Biotechnology Taskforce and the boards of Energex Ltd, WorkCover Queensland, AGEN Biomedical Limited and Protagonist Ltd. Jane was an inaugural member of the Queensland Premier's Smart State Council and is a member of the University of Queensland Senate. She has an M.B.A. from the Harvard Business School where she studied agribusiness and the health sector. Jane is the current Chairman of IMBcom Limited, the commercialization company of the Institute for Molecular Bioscience, and is Past President of the Australian Institute of Company Directors - Queensland Division, as well as a director of Sonic Healthcare Ltd and CathRx Ltd.

back to top

Senior Management

Mr Paul Wright M.A., F.A.I.C.D.
Chief Executive Officer [Effective 1 March 2011]

Mr. Wright was appointed as Chief Executive Officer and a director of the Company on February 24, 2011 with an effective date of March 1, 2011. Mr. Wright has experience as Chief Executive Officer with two global technology companies and extensive experience in international management consulting and commercial development with a focus on manufacturing industries. Between 2008 and 2011, Paul Wright has acted as a company director for two Australian private companies (Metallic Waste Solutions Pty Ltd and Comcater Pty Ltd). During 2006 and 2007, Mr. Wright was Chief Executive Officer of Vision BioSystems, a major subsidiary of Vision Systems Limited, which develops, manufactures and markets diagnostic instruments and consumables worldwide. Following the acquisition of Vision Systems Limited by Danaher Corporation in 2006, Mr. Wright worked for Danaher Corporation to assist with the integration of Vision Systems into the new parent until 2007. From 1999 to 2006, Mr. Wright was Chief Executive Officer of Invetech, a leading international product development consultancy. Prior to this, Mr. Wright gained extensive experience in international strategy consulting and commercial development, with a focus on manufacturing industries including roles at TNT Logistics and Bain & Company. Mr. Wright holds a Masters degree in Aeronautical Engineering from the University of Cambridge, a Diploma in Production Methods & Management from the University of Cambridge and has studied Corporate Finance at the London Business School. Mr. Wright is a Fellow of the Australian Institute of Company Directors.

back to top

Dr Alastair Hodges BSc. (Hons.), Ph.D.
Chief Scientist

Alastair has been working in the field of electrochemical sensors for the last 12 years and has served as our Chief Scientist since April 2002. Alastair has a BSc. (Hons.) in chemistry and gained a Ph.D. in electrochemistry from the University of Melbourne in 1987. Alastair worked as a research scientist, then senior and principle research scientist in the Defense Science and Technology Organization and the CSIRO in the fields of electrochemistry and transport processes, particularly involving membranes, until 1995, when he joined Memtec Limited to work on sensor technologies. Memtec was involved in the operation, design and installation, of filtration and separation products for water supply and waste water recycling plants. From 1999 to 2001 Alastair led a team that worked in the US on the development of glucose sensor technology. Alastair has published thirteen papers in refereed journals and is the primary inventor of patents in 34 families issued and pending.

back to top

Mr Salesh Balak B.A., C.A.
Chief Financial Officer

Salesh has served as our Chief Financial Officer since November 2006 and as a director of Universal Biosensors Pty Ltd since September 2010. Prior to joining Universal Biosensors, he was chief financial officer and company secretary of Pearl Healthcare Limited, an ASX listed entity engaged in the manufacturing and healthcare sector. Salesh joined Pearl Healthcare Limited in April 2003 initially as its Group Accounting Manager and was promoted to Chief Financial Officer in June 2004. While at Pearl Healthcare Limited, Salesh was instrumental in the successful acquisition of four businesses and integration of its existing businesses. Prior to joining Pearl Healthcare Limited, Salesh spent 13 years in the Business Services, Audit and Financial Advisory Services divisions of KPMG in both the Melbourne and Fiji offices. He holds a Bachelor of Arts in accounting and economics and is a member of the Institute of Chartered Accountants and Certified Practicing Accountants.

back to top

Mr Garry Chambers
Vice President of Operations

Garry has served as our Head of Engineering since April 2002 and as Vice President of Operations since September 1, 2006. Prior to joining Universal Biosensors Pty Ltd, Garry was a senior engineer with MediSense (UK), one of the first biotechnology companies to produce mass market biosensors. In 1991, Garry relocated to Australia to join Memtec Limited, a company involved in the operation, design and installation, filtration and separation of products for water supply and waste water recycling plants, to work on sensor technologies. From 1999 to 2001, he was part of a core team based in the United States that developed the glucose sensor technology. Garry is an inventor on patents in 9 families issued and pending.

back to top

Dr Adrian Oates BSc, MSc (Preliminary), Ph.D.
Vice President Quality and Regulatory

Adrian joined us in September 2007 as Vice President, Quality & Regulatory having spent over 20 years in the device, biological and pharmaceutical health care industries. His early career was as a research scientist and manager as well as head of project management at CSL Limited where a number of intravenous protein based replacement products were developed and commercialized. In 2000, he was appointed as Quality Director to oversee the implementation of the new Good Manufacturing Practices Code. He moved in 2004 to Cochlear Limited as Vice President, Quality & Regulatory where he was involved in the worldwide registration, accreditation and launch of a new sterile implantable medical device lead. After this, Adrian returned to CSL Limited as Quality Director where successful FDA accreditation for Influenza vaccine was obtained. He holds a BSc (Biochemistry/Microbiology), a Master of Science (Preliminary) and a Doctor of Philosophy (Medicine) from Monash University.

back to top

Dr Fred Davis BEng, PhD, GAICD.
Vice President Business Development

Fred joined us as Vice President, Business Development in November 2011. His experience includes 20 years leading the development of diagnostic instruments and first-of-kind devices with Invetech.

As Managing Director for Invetech since 2006 and Director of Instrument Development (2000-2006), Fred led an international business development team; driving strong international business growth and building long term partnerships with leaders in diagnostics and life sciences.

Fred holds a PhD in Mechanical Engineering from Bristol University, a Bachelor of Mechanical Engineering (Hons.1st) from Auckland University, a Graduate Certificate of Executive Business Administration from Mt.Eliza, and a Graduate Certificate of Technology Management from APESMA. He is a Graduate of the Australian Institute of Company Directors.

back to top

Mr Cameron Billingsley L.L.B. (Hons.), B.A.
Company Secretary

Cameron has served as our Company Secretary since February 2006. Cameron has been involved with us as a corporate attorney since our incorporation in 2001. Cameron is a corporate lawyer and is the principal and founder of PFM Legal Pty Ltd, a company established to provide company secretarial and general counsel services to Australian technology businesses and has been engaged in this business since April 2004. Cameron provides his services as Company Secretary and general legal counsel to us through PFM Legal Pty Ltd. From January 2001 through April 2004, Cameron was a corporate lawyer at Piper Alderman Solicitors in Sydney. Cameron is also company secretary of a number of life sciences companies and PFM Cornerstone Ltd which helps Australian technology businesses commercialize their technologies. Cameron holds a Bachelor of Laws (Honors) and Bachelor of Arts from the University of Technology, Sydney in Australia.

back to top

updated 8th May, 2012

© Copyright 1996-2019 irasia.com Ltd. All rights reserved.

DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd be liable for damages resulting from the use of the information provided on this website. TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for use on this website. All rights under applicable laws are hereby reserved. Reproduction of this website in whole or in part without the express written permission of irasia.com Ltd is strictly prohibited. TERMS OF USE: Please read the Terms of Use governing the use of our website.